Nobel Prize in chemistry awarded to two women who developed CRISPR, a revolutionary gene-editing tool
By Ben Guarino,
Washington Post
| 10. 07. 2020
A pair of scientists — Jennifer A. Doudna, a biochemist at the University of California at Berkeley, and Emmanuelle Charpentier, a French microbiologist — won the 2020 Nobel Prize in chemistry Wednesday for their work developing a revolutionary gene-editing tool that can change the DNA of plants and animals with extraordinary precision. The technique, called CRISPR -Cas9, is already being used as a cancer therapy and to cure inherited diseases.
“This year’s prize is about rewriting the code of life,” said Goran K. Hansson, secretary general of the Royal Swedish Academy of Sciences.
This was the first time two women jointly won a Nobel in chemistry. “I wish that this will provide a positive message, specifically, to young girls who would like to follow the path of science,” Charpentier told reporters Wednesday morning.
“I’m over the moon, I’m in shock, I couldn’t be happier,” Doudna said at a University of California at Berkeley news conference. She said she and Charpentier are “waving to each other across the Atlantic right now.”
Francis Collins, director of the National Institutes of Health, said...
Related Articles
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Simar Bajaj, The New York Times | 11.27.2025
A common cold was enough to kill Cora Oakley.
Born in Morristown, N.J., with virtually no immune system, Cora was diagnosed with severe combined immunodeficiency, a rare genetic condition that leaves the body without key white blood cells.
It’s better...
By Rachel Hall, The Guardian | 11.30.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
